|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
BioSeek, Inc. And UCB, Inc. (UCBJF.PK) Establish New Compound Evaluation Collaboration, Expand Previous Agreement
1/7/2009 8:21:42 AM
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--BioSeek, Inc., a pioneer in the application of predictive human biology to drug discovery, announced today that it has entered into a new and expanded agreement with UCB, a global biopharmaceutical company based in Belgium. Under the collaboration, BioSeek will, over the next year, both carry out broad-based profiling of selected UCB new chemical and biological entities, and guide lead optimization of a specific phenotypic hit previously identified by UCB and further characterized in BioMAP screens. According to the terms of the agreement, BioSeek will receive various payments from UCB, including an upfront technology license fee, research funding, and preclinical and clinical milestone payments based on candidate advancement enabled by the BioMAP platform.
|
|
|
|
|
|
|
|
|
|
|